Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES
Document Type and Number:
WIPO Patent Application WO/2021/142454
Kind Code:
A1
Abstract:
This disclosure provides compositions and methods for the targeted and localized in vivo delivery of oligonucleotides. Compositions containing targeted oligonucleotide-HES conjugates are provided as are methods of making and using the conjugates in therapeutic, diagnostic, and other applications. The oligonucleotide-HES complexes contained in the targeted oligonucleotide-HES conjugates can cross membranes in a receptor-independent manner and can deliver oligonucleotides to complementary sequences in the cytosol of live cells in vivo. The targeted oligonucleotide-HES conjugates have uses that include the targeted and/or localized delivery of antisense oligonucleotides, siRNAs, shRNAs, Dicer substrates, miRNAs, anti-miRNA, and other nucleic acid sequence in a living organism.

Inventors:
PACKARD BEVERLY (US)
KOMORIYA AKIRA (US)
Application Number:
PCT/US2021/012988
Publication Date:
July 15, 2021
Filing Date:
January 11, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONCOLMMUNIN INC (US)
International Classes:
A61K31/713; A61K31/7088
Foreign References:
US20160040161A12016-02-11
US20130344508A12013-12-26
Attorney, Agent or Firm:
HOOVER, Kenley, K. (US)
Download PDF: